Healthcare & Life Sciences
Replimune
United Statesreplimune.com
Replimune is a startup based in the United States, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
3
Investors
About Replimune
Based in the United States, Replimune is a startup. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Replimune is a clinical-stage biotech company developing oncolytic immunotherapies designed to induce a systemic and durable immune response against a variety of solid tumors.
Explore Replimune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.